Major Developments
CSPC Pharmaceutical Group (01093) has signed a joint venture agreement with AstraZeneca to deepen their strategic collaboration through the establishment of a new company.
YouRan Dairy (09858) announced that its subsidiary plans to conduct an asset swap, aiming to optimize business division and resource allocation.
Vizlink Biotech-B (09887) reported that its Vilitin™ Phase II study for hepatocellular carcinoma treatment has successfully entered the expansion phase.
Flat Glass Group (06865) intends to invest approximately 60.04 million yuan to acquire a 60% stake in Shanghai Fulai Ruicheng.
China Silver Group (00815) announced that exploration results support continued exploration activities at its Xigaze mine.
Boan Biological (06955) has submitted a marketing authorization application in Brazil for its Aflibercept ophthalmic injection solution.
Luye Pharma Group (02186) confirmed that its innovative drug LY03015 (VMAT2 inhibitor/Sigma-1R agonist) has successfully completed a bridging clinical trial in the United States.
China Spring Education (01969) plans to acquire Dublin Business School for $127.5 million, expanding its overseas higher education footprint.
Share Buybacks and Stake Changes
Xiaomi Corporation (01810) spent approximately 49.98 million Hong Kong dollars on August 5 to buy back 1.804 million shares.
Midea Group (00300) used about 42.86 million yuan on August 5 to repurchase 504,900 A-shares.
COSCO Shipping Holdings (01919) spent roughly 16.77 million yuan on August 5 to buy back 1.0956 million A-shares.
Conch Cement (00914) invested about 15.6 million yuan on August 5 to repurchase 880,000 A-shares.
China Petroleum & Chemical Corporation (00386) spent 9.28 million yuan on August 5 to buy back 1.85 million A-shares.
HSBC Holdings (00005) announced plans to buy back shares worth up to $1 billion.
Operational and Financial Results
Beone Medicines (06160) reported its first-half results, with an adjusted net profit of approximately $819.5 million, marking a 111% increase year-over-year.
Uni-President China Holdings (00220) released its interim results, showing a net profit attributable to shareholders of 1.402 billion yuan, up 8.99% from a year earlier.
Manulife Financial-S (00945) posted second-quarter results with core earnings of 1.9 billion Canadian dollars, a 12% increase year-over-year.
Rongchang Bio (09995) projected a net profit attributable to shareholders of around 4.7 billion yuan by mid-2026.
Jie Li Bao (08017) reported that its registered user count reached approximately 920,800 in July, a 6.7% rise year-over-year.
China Shengmu-PF (01432) issued a profit alert, expecting a profit attributable to shareholders of at least 60 million yuan in the first half, reversing a loss from the prior year.
Jiaogepengyou Holdings (01450) also issued a profit alert, anticipating a mid-term net profit ranging from 86 million to 93 million yuan, representing a 52.6% to 65.0% increase year-over-year.
Concord New Energy (00182) reported total equity power generation of 5,033.26 GWh for the first seven months of the year.
Sunac China Holdings (00884) recorded cumulative contracted sales of approximately 5.64 billion yuan for the first seven months, a 12.35% month-over-month increase.
Zhengrong Real Estate (06158) posted cumulative contracted sales of about 2.473 billion yuan for the first seven months, down 8.44% year-over-year.
Muyuan Foods (02714) reported July commercial pig sales revenue of about 8.897 billion yuan, a 23.56% decrease year-over-year.
Comments